BRAHMS AG

B·R·A·H·M·S explores, develops, and produces new diagnostic testing procedures to improve the diagnosis of life-threatening diseases, thereby enhancing their treatment. The company focuses on in vitro and in vivo diagnostic substances in the biotechnology field.This work is based on more than 400 employees and their own patented biomarkers, providing patients and medical professionals with medically and economically superior diagnostic insights.B·R·A·H·M·S products serve customers in 65 countries worldwide and are leaders in their specialized market.B·R·A·H·M·S GmbH is the legal entity and part of Thermo Fisher Scientific. All B·R·A·H·M·S products are sold globally under the Thermo Scientific brand. Thermo Fisher Scientific's mission is to enable our customers to make the world healthier, cleaner, and safer.On September 3, 2009, Thermo Fisher Scientific Inc. (NYSE: TMO) signed a definitive agreement to acquire BRAHMS AG for €330 million (approximately $470 million).